Obstetrics

An expert commentary on Practice Bulletin No. 156: Obesity in Pregnancy.

“Women have very polarized views about induction... some are keen to be induced near their due date ... Others, however, feel that nature knows best and induction is meddlesome."

Dutch researchers reviewed data from 62,000 Rh-negative women to determine how to best detect and treat severe hemolytic disease of the fetus and newborn.

An interview with the doctor behind the near-elimination of US deaths due to Rh disease.

A better understanding of the care and outcomes of women with severe morbidity who survive should provide insight into ways to improve care for all women and reduce both severe morbidity and mortality.

In Florida, the public is worried and the news keeps getting worse.

A study in Tehran tested this noninvasive intervention on women with uncomplicated pregnancies at full term.

For Contemporary OB/GYN, Dr Bobby Lazzara discusses key findings of a study published in Science Translational Medicine. The study looked at how delivery mode impacted the gut microbiome of infants and wondered about the long-term impact.

Pregnant women are worried, and their concern is warranted. Here is what we know now and what’s being done about this health crisis.

Clinicians should be aware of the potential for confounding of NIPT results by cfDNA released from a vanishing twin.

Antenatal anti-D immunoglobulin helps reduce the incidence of RhD alloimmunization in Rh-negative women, but should it be administered to non-sensitized women prophylactically?

Seven strategies to fight the rising tide.

A study in Sweden looked at safety and effectiveness.

A study looked at the outcomes for women who had prolonged premature rupture of membranes at term.

Research supports moving from routine antenatal anti-Rhesus D (RhD) prophylaxis in unsensitized RhD-negative pregnant women to a targeted approach.

A study found that IV drug abusing pregnant women had a two-fold higher relative risk of alloimmunization.

Expanded screening answers questions that were unanswerable in the past, but brings with it new uncertainties.

The CDC has released new guidelines for interpreting Zika virus tests. Also, is the trend for triplet and higher-order birth rate going up or down? Plus: Do preemies benefit from maternal vaccines?

A recent study in Austria looked at the results in more than 200 labor inductions.

A commentary on ACOG Practice Bulletin Number 154: Operative Vaginal Delivery by Charles J Lockwood, MD, MHCM.

The problems go beyond fetal metabolic programming. Obesity has effects on fetal neurodevelopment.

This forceps-aided rotation can be used when the fetus is occiput posterior and the head is low in the pelvis.

An ob/gyn saves a patient's life and uterus, but then is faced with a lawsuit.

Home birth can carry risks, regardless of whether the woman has previously delivered, and prior cesarean delivery can also carry risks. This session examined the risks that can occur among women who choose home birth with a history of at least one cesarean delivery.

A new study looks at whether breast density letters are too difficult for the typical woman to understand. Plus: The FDA issues a warning on fluconazole and miscarriage. Also, do irregular menses provide protection against ovarian cancer or increase risk?